Literature DB >> 33594634

Validation of Sinhala version of Psoriasis Epidemiology Screening Tool.

Achala Liyanage1, S Verni2, G Liyanage3, V De Silva3, J Akarawita4, C Gunasekera4, J Rubasinghe2, S Imafuku5, S Lekamwasam3.   

Abstract

INTRODUCTION/
OBJECTIVES: Psoriatic arthritis (PsA) occurs in one-third of patients with psoriasis and mostly remains undetected leading to debilitating deforming arthritis, eventually. The Psoriasis Epidemiology Screening Tool (PEST) is a quick and valid tool, widely used to detect PsA in clinical practice, and it has been validated to many languages. In this study, we intended to validate a Sinhala version of the PEST and assess its psychometric properties.
METHODS: The Sinhala version of the questionnaire was tested on 199 patients with psoriasis attending the dermatology clinic at a tertiary care National Hospital in Sri Lanka. Patients who were detected to have PsA previously (n = 5) and those with other rheumatologic conditions (n = 12) were excluded. All patients were examined by a dermatologist, and demographic and disease characteristics were obtained. All patients were assessed by two rheumatologists who were blinded to the answers provided in the questionnaire. The diagnosis of PsA was made based on the CASPAR criteria.
RESULTS: We observed the total PEST score of 3 or more to be the best cutoff value to screen for PsA. This cutoff value showed the highest Youden index (sensitivity = 0.89, specificity = 0.95). In the ROC analysis, the area under the curve of the PEST_sv was 0.95 (SE 0.02, p < 0.001). PEST_sv total score showed a significant correlation with body surface area involved but not with Dermatology Life Quality Index or Psoriasis area and severity index score.
CONCLUSION: The Sinhala version of PEST demonstrated satisfactory performance as a screening tool for PsA. Key Points • Psoriatic arthritis (PsA) is the most debilitating complication of psoriasis and lack of quick, valid screening tool is a limiting factor for early identification in Sri Lankan context. • Sinhala version of the Psoriasis Epidemiology Screening Tool (PEST_sv) was tested on 199 patients with psoriasis and examined for the diagnosis of PsA according to Classification of Psoriatic Arthritis (CASPAR) criteria. • PEST_sv score of 3 or more was observed to be the best cutoff value to screen for PsA with sensitivity and specificity of 0.89 and 0.95 respectively. • PEST_sv demonstrated satisfactory performance as a screening tool for PsA.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  PEST; Psoriasis; Psoriatic arthritis; Validation study

Year:  2021        PMID: 33594634     DOI: 10.1007/s10067-021-05633-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

1.  Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire.

Authors:  G H Ibrahim; M H Buch; C Lawson; R Waxman; P S Helliwell
Journal:  Clin Exp Rheumatol       Date:  2009 May-Jun       Impact factor: 4.473

2.  Hautentzündungen mit Arthritis, Synovitis und Enthesitis. Teil 1: Psoriasisarthritis, SAPHO-Syndrom, Morbus Still, Morbus Behçet.

Authors:  Christian K Huhn; Franziska Schauer; Christoph M Schempp; Nils Venhoff; Stephanie Finzel
Journal:  J Dtsch Dermatol Ges       Date:  2019-01       Impact factor: 5.584

Review 3.  Psoriatic arthritis: A permanent new challenge for dermatologists (Review).

Authors:  Alina Dinu; Stefana Bucur; Rodica Olteanu; Traian Constantin; Anca Raducan; Mara Baetu; Maria-Magdalena Constantin
Journal:  Exp Ther Med       Date:  2019-12-12       Impact factor: 2.447

4.  Quality of life in patients with psoriasis in northern Taiwan.

Authors:  Tung-Yi Lin; Lai-Chu See; Yu-Ming Shen; Chung-Yu Liang; Hsin-Ning Chang; Yin-Ku Lin
Journal:  Chang Gung Med J       Date:  2011 Mar-Apr

Review 5.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome.

Authors:  D D Gladman; C Antoni; P Mease; D O Clegg; P Nash
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

6.  Psoriatic arthritis screening tools.

Authors:  Abrar A Qureshi; Patrick Dominguez; Kristina C Duffin; Dafna D Gladman; Philip Helliwell; Philip J Mease; M Elaine Husni
Journal:  J Rheumatol       Date:  2008-07       Impact factor: 4.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.